Fig. 2From: A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) — a randomised feasibility study using the trial within a cohort (TwiC) methodologyFlow chart demonstrating participant screening, eligibility and enrolment in TILTBack to article page